ALPHA TWA (T-Wave Alternans) trial pinpoints ICD (implantable cardioverter defibrillator) need
This article was originally published in Clinica
Executive Summary
Using Cambridge Heart's noninvasive electrocardiogram-based Microvolt T-Wave Alternans (TWA) test on patients with non-ischaemic cardiomyopathy could pinpoint the one third of patients who are unlikely to benefit from an implantable cardioverter defibrillator (ICD).